MENU
+Compare
TNXP
Stock ticker: NASDAQ
AS OF
Jun 23 closing price
Price
$32.79
Change
-$1.53 (-4.46%)
Capitalization
238.08M

TNXP Tonix Pharmaceuticals Holding Corp Forecast, Technical & Fundamental Analysis

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TNXP with price predictions
Jun 23, 2025

TNXP's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for TNXP moved out of overbought territory on June 09, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 instances where the indicator moved out of the overbought zone. In of the 20 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TNXP as a result. In of 66 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TNXP turned negative on June 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where TNXP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TNXP advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

TNXP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 58 cases where TNXP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.337) is normal, around the industry mean (16.460). P/E Ratio (0.092) is within average values for comparable stocks, (58.911). TNXP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.291). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (7.220) is also within normal values, averaging (252.526).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TNXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TNXP is expected to report earnings to fall 340.49% to -682 cents per share on August 11

Tonix Pharmaceuticals Holding Corp TNXP Stock Earnings Reports
Q2'25
Est.
$-6.83
Q1'25
Beat
by $22.84
Q4'24
Missed
by $5.86
Q3'24
Beat
by $2.70
Q2'24
Missed
by $14.05
The last earnings report on May 12 showed earnings per share of $2.84, beating the estimate of -2000 cents. With 522.85K shares outstanding, the current market capitalization sits at 238.08M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANBX36.700.13
+0.36%
Oakmark Equity and Income Institutional
MIEGX11.10N/A
N/A
BNY Mellon Emerging Markets Inv
CFWCX25.99N/A
N/A
Calvert Global Water C
SMVZX11.69N/A
N/A
Virtus Ceredex Mid-Cap Value Equity R6
BPGSX13.33N/A
N/A
Boston Partners Global Sustainablty Ins

TNXP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with ICU. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then ICU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-4.46%
ICU - TNXP
77%
Closely correlated
-5.84%
NEVPF - TNXP
37%
Loosely correlated
N/A
TOVX - TNXP
35%
Loosely correlated
-0.76%
CRVS - TNXP
32%
Poorly correlated
-5.09%
RNAZ - TNXP
28%
Poorly correlated
-0.92%
More

Groups containing TNXP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-4.46%
TNXP
(2 stocks)
100%
Closely correlated
-5.15%